First patients for trial that investigates adaptive treatment for ovarian cancer
The Anticancer Fund and Barts Charity are co-funding the ACTOv-trial, which has enrolled its first patients in the United Kingdom. This study is investigating a new personalised treatment approach for ovarian cancer that has returned after previous chemotherapy. The aim is to prolong patients’ survival and reduce side-effects.
Promising trial in pancreatic cancer enrols first patient
Why medicines regulators should start a 'Drug Evidence Watch' process
We present ambitious recommendations for the EU pharmaceutical legislation
First patient in study to treat prostate cancer more personally with an on/off-strategy.
Our groundshot: better and longer lives for people with cancer
Ensuring completeness and timeliness of cancer treatment guidelines
Gauthier Bouche, Lydie Meheus. Ensuring completeness and timeliness of cancer treatment guidelines. Nature Reviews Clinical Oncology, 20 May 2022. doi.org/10.1038/s41571-022-00646-w
Parents of children with cancer despair because treatments are lacking
